Allergy Diagnostics and Therapeutics Market by Products (Instruments, Consumables, Services), Allergen Type, Test Type, Drug Class, End-Users, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2019 to 2026

  • Publish Date: Jul, 2019
  • Report ID: 396098
  • Category: Healthcare
  • Pages: 250
$4,700

Global allergy diagnostics and therapeutics market is expected to reach USD 57.31 Billion by 2026 at a CAGR of 6.23% during the forecast period 2019-2026. Rising instances of allergy diseases and growing demand for IVD tests for allergy diagnosis are the two major factors contributing to the growth of the market.

Market Overview:

An allergy is defined as a hypersensitivity disease in the body immune system. Allergy arises when an individual’s immune system reacts to any harmless substances known as allergens. Factors which cause allergy include pet dander, pollen, and dust mite excretion. There are various kinds of allergies such as drug allergy, dust allergy, skin allergy, food allergy, mold allergy and allergy to insect stings. Allergic reactions cause destructive consequences for human wellbeing resulting in huge dreariness due to lung, dermatologic and otolaryngologic issue.

Report Description:                                                                                                                       

  • The base year for the study has been considered 2018, the historic year 2016 and 2017 and, the forecast period considered is from 2019 to 2026. The allergy diagnostics and therapeutics market is analyzed on the basis of value (USD Billion).
  • The study delivers a comprehensive analysis of global allergy diagnostics and therapeutics market by products, allergen type, test type, drug class, end-users, and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global allergy diagnostics and therapeutics market. This report incorporates the industry analysis which is focused on providing an extensive view of the allergy diagnostics and therapeutics market.
  • The study also includes attractiveness analysis of products, allergen type, test type, drug class, end-users and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the allergy diagnostics and therapeutics market and a comparative analysis based on their business overviews, industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Rising instances of allergy diseases
  • Growing demand for IVD tests for allergy diagnosis
  • Evolution of technologically advanced allergy diagnostics products
  • Rising healthcare expenditure triggering the development of effective allergy diagnostic & therapeutic products.

Restraints:

  • Low adoption and penetration in developing countries due to the high cost of technology
  • Presence of ambiguous regulatory framework

Opportunities:

  • Growing demand from emerging market.

Challenges:

  • Severe government regulation
  • High capital requirements
  • Lack of awareness

Global Allergy Diagnostics and Therapeutics Market Key Findings:

All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The allergy diagnostics and therapeutics market is segmented on the basis of products, allergen type, test type, drug class, and end-users.

  • The products segment is classified into instruments, consumables, and services. The consumables segment has dominated the market by holding the highest market share of 52.84% in 2018 as they are an indispensable element in allergy detection.
  • The allergen type segment includes food, inhaled and drug. The inhaled segment valued around USD 17.97 billion in 2018. Rising instances of respiratory allergies and asthma are responsible for the dominance of inhaled allergen segment. It is due to the growing demand for allergy testing and introduction of specific allergen for the detection of allergy.
  • The test type segment is divided into segments such as in vivo and in vitro. In vivo segment is anticipated to grow with the highest CAGR of 7.18% over the forecast period owing to related benefits such as ease of use, time efficiency, wider availability and sensitivity for clinically valid allergies.
  • The drug class segment includes antihistamines, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, decongestants, immunomodulators, auto-injectable epinephrine, and immunotherapy. The antihistamines segment dominated the market with the highest market share of 34.19% in 2018 due to associated benefits with its usage and wide applications in the treatment of allergy diseases.
  • The end-users segment includes academic research institutes, hospitals, and diagnostic laboratories. The hospitals and diagnostic laboratories segment is anticipated to hold the highest share of 38.48% in 2026 due to the increasing use of immunoassay tests in allergy diagnosis coupled with improvements in screening techniques which would enable accurate disease diagnosis and stratification for appropriate treatment.

Regional Segmentation Analysis:                                                                                           

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global allergy diagnostics and therapeutics market with USD 12.99 billion in 2018 where as the Asia Pacific region is growing at the faster rate.

  • North America is dominating the market due to the rising number of cases of allergic respiratory disorders and the growing awareness regarding allergy diagnostics coupled with the increasing acceptance of in-vitro blood tests in the region.
  • Asia Pacific region is growing rapidly in the market. It is due to the presence of high unmet needs, improvising healthcare infrastructure and demand for minimally invasive diagnostic tools from the consumer end.

Global Allergy Diagnostics and Therapeutics Market Competitive Analysis:

Key players in the allergy diagnostics and therapeutics market are bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group and Alcon Laboratories. For instance, in July 2015, Thermo Fisher launched the Phadia 2500E Laboratory System. This product offers better diagnostic solutions by detecting and quantifying the relevant antibodies in blood samples of the patients to identify the possible allergy or autoimmune sensitivity.

*All our reports are customizable as per customer requirements

This study forecasts revenue growth and volume at global, regional, and country levels from 2016 to 2026. Fior Market Research has segmented the global allergy diagnostics and therapeutics market on the basis of below-mentioned segments:

Global Allergy Diagnostics and Therapeutics Market, By Products:

  • Instruments
  • Consumables
  • Services

 Global Allergy Diagnostics and Therapeutics Market, By Allergen Type:

  • Food
  • Inhaled
  • Drug

 Global Allergy Diagnostics and Therapeutics Market, By Test type:

  • In Vivo
  • In Vitro

 Global Allergy Diagnostics and Therapeutics Market, By Drug class:

  • Antihistamines
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Decongestants
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy

 Global Allergy Diagnostics and Therapeutics Market, By End-Users:

  • Academic Research Institutes
  • Hospitals
  • Diagnostic Laboratories

 Global Allergy Diagnostics and Therapeutics Market, By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Asia-Pacific
  • Japan
  • China
  • India
  • South America
  • Brazil
  • Middle East and Africa         
  • UAE
  • South Africa
  1. INTRODUCTION
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. RESEARCH SCOPE
    4. CURRENCY
  2. RESEARCH METHODOLOGY AND ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. TOP INVESTMENT POCKETS
      1. MARKET ATTRACTIVENESS ANALYSIS BY PRODUCTS
      2. MARKET ATTRACTIVENESS ANALYSIS BY ALLERGEN TYPE
      3. MARKET ATTRACTIVENESS ANALYSIS BY TEST TYPE
      4. MARKET ATTRACTIVENESS ANALYSIS BY DRUG CLASS
      5. MARKET ATTRACTIVENESS ANALYSIS BY END-USERS
      6. MARKET ATTRACTIVENESS ANALYSIS BY REGION
    2. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF BUYERS
      5. INTENSITY OF COMPETITIVE RIVALRY
    3. PESTEL ANALYSIS
    4. INDUSTRY SWOT ANALYSIS
    5. INDUSTRY TRENDS
    6. MICRO AND MACRO FACTORS AFFECTING GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS 
    7. CUSTOMERS/BUYERS BY REGIONS
  5. MARKET DYNAMICS
    1. MARKET EVALUATION
    2. DRIVERS
      1. RISING INSTANCES OF ALLERGY DISEASES
      2. GROWING DEMAND FOR IVD TESTS FOR ALLERGY DIAGNOSIS
      3. EVOLUTION OF TECHNOLOGICALLY ADVANCED ALLERGY DIAGNOSTICS PRODUCTS
      4. RISING HEALTHCARE EXPENDITURE TRIGGERING DEVELOPMENT OF EFFECTIVE ALLERGY DIAGNOSTIC & THERAPEUTIC PRODUCTS.
    3. RESTRAINTS
      1. LOW ADOPTION AND PENETRATION IN DEVELOPING COUNTRIES DUE TO HIGH COST OF TECHNOLOGY
      2. PRESENCE OF AMBIGUOUS REGULATORY FRAMEWORK
    4. OPPORTUNITIES
      1. GROWING DEMAND FROM EMERGING MARKET
    5. CHALLENGES
      1. SEVERE GOVERNMENT REGULATION
      2. HIGH CAPITAL REQUIREMENTS
      3. LACK OF AWARENESS
  6. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY PRODUCTS
    1. SEGMENT OVERVIEW
    2. INSTRUMENTS
    3. CONSUMABLES
    4. SERVICES
  7. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY ALLERGEN TYPE
    1. SEGMENT OVERVIEW
    2. FOOD
    3. INHALED
    4. DRUG
  8. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY DRUG CLASS
    1. SEGMENT OVERVIEW
    2. ANTIHISTAMINES
    3. CORTICOSTEROIDS
    4. MAST CELL STABILIZERS
    5. LEUKOTRIENE INHIBITORS
    6. NASAL ANTICHOLINERGICS
    7. DECONGESTANTS
    8. IMMUNOMODULATORS
    9. AUTOINJECTABLE EPINEPHRINE
    10. IMMUNOTHERAPY
  9.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY TEST TYPE
    1. SEGMENT OVERVIEW
    2. IN VIVO
    3. IN VITRO
  10. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY END-USERS
    1. SEGMENT OVERVIEW
    2. ACADEMIC RESEARCH INSTITUTES
    3. HOSPITALS
    4. DIAGNOSTIC LABORATORIES
  11. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY REGIONAL ANALYSIS
    1. SEGMENT OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. U.K.
      4. ITALY
      5. SPAIN
      6. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. REST OF APAC
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF SA
    6. MIDDLE EAST AND AFRICA
      1. UAE
      2. SOUTH AFRICA
      3. REST OF MEA
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET-COMPETITIVE LANDSCAPE
    1. OVERVIEW
    2. MARKET SHARE OF KEY PLAYERS IN THE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET
      1. GLOBAL COMPANY MARKET SHARE
      2. NORTH AMERICA COMPANY MARKET SHARE
      3. EUROPE COMPANY MARKET SHARE
      4. APAC COMPANY MARKET SHARE
    3. COMPETITIVE SITUATIONS AND TRENDS
      1. PRODUCT LAUNCHES AND DEVELOPMENTS
      2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
      3. MERGERS & ACQUISITIONS
      4. EXPANSIONS
  13. COMPANY PROFILES
    1. BIOMERIEUX
      1. BUSINESS OVERVIEW
      2. COMPANY SNAPSHOT
      3. KEY FINANCIAL
        1. REVENUE ANALYSIS
        2. MARGIN ANALYSIS
        3. COMPANY SEGMENT ANALYSIS
      4. COMPANY PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
      6. SWOT ANALYSIS
    2. THERMO FISHER SCIENTIFIC
    3. DANAHER CORPORATION
    4. OMEGA DIAGNOSTICS
    5. HITACHI CHEMICAL DIAGNOSTICS
    6. STALLERGENES GREER
    7. SIEMENS HEALTHCARE
    8. LINCOLN DIAGNOSTICS
    9. HYCOR BIOMEDICAL
    10. HOB BIOTECH GROUP
    11. ALCON LABORATORIES

LIST OF TABLE

  1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE (USD MILLION)
  2. GLOBAL INSTRUMENTS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  3. GLOBAL CONSUMABLES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  4. GLOBAL SERVICES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  7. GLOBAL INHALED ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  8. GLOBAL DRUG ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  9. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  10. GLOBAL IN VIVO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  11. GLOBAL IN VITRO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  13. GLOBAL ANTIHISTAMINES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  14. GLOBAL CORTICOSTEROIDS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  15. GLOBAL MAST CELL STABILIZERS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  16. GLOBAL LEUKOTRIENE INHIBITORS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  17. GLOBAL NASAL ANTICHOLINERGICS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  18. GLOBAL DECONGESTANTS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  19. GLOBAL IMMUNOMODULATORS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  20. GLOBAL AUTOINJECTABLE EPINEPHRINE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  21. GLOBAL IMMUNOTHERAPY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  22. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  23. GLOBAL ACADEMIC RESEARCH INSTITUTES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  24. GLOBAL HOSPITALS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  25. GLOBAL DIAGNOSTIC LABORATORIES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  26. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  27. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  28. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  29. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  30. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  31. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  32. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  33. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  34. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  35. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  36. U.S ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  37. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  38. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  39. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  40. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  41. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  42. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  43. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  44. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  45. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  46. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  47. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  48. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  49. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  50. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  51. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  52. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY INDUSTRY VERTICAL, 2016–2026 REVENUE(USD MILLION)
  53. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  54. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  55. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  56. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  57. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  58. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  59. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  60. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  61. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  62. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  63. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  64. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  65. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  66. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  67. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  68. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  69. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  70. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  71. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  72. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  73. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  74. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  75. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  76. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  77. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  78. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  79. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  80. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  81. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  82. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  83. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  84. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  85. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  86. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  87. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  88. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  89. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  90. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  91. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  92. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  93. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  94. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  95. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  96. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  97. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  98. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  99. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  100. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  101. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  102. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  103. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  104. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  105. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  106. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  107. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  108. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  109. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  110. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  111. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  112. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  113. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  114. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  115. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  116. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  117. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  118. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  119. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  120. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  121. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  122. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)

LIST OF FIGURES 

  1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SEGMENTATION
  2. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET: RESEARCH METHODOLOGY
  3. MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  4. MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  5. DATA TRIANGULATION
  6. PORTER’S FIVE FORCES ANALYSIS
  7. VALUE CHAIN ANALYSIS
  8. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY PRODUCTS
  9. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY ALLERGEN TYPE
  10. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY TEST TYPE
  11. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY DRUG CLASS
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY END-USERS
  13. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY REGION
  14. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET: DYNAMICS
  15. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY PRODUCTS (2018 & 2026)
  16. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY ALLERGEN TYPE (2018 & 2026)
  17. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY TEST TYPE (2018 & 2026)
  18. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY DRUG CLASS (2018 & 2026)
  19. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY APPLICATION (2018 & 2026)
  20. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY END-USERS (2018 & 2026)
  21. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY REGIONS (2018 & 2026)
  22. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY COMPANY (2018)

EXTRA CUSTOMIZATION

  • NORTH AMERICA
    • U.S.
    • CANADA
    • MEXICO
  • EUROPE
    • GERMANY
    • FRANCE
    • SWEDEN
    • NETHERLANDS
    • U.K.
    • ITALY
    • SPAIN
    • TURKEY
    • SWITZERLAND
    • BELGIUM
    • REST OF EUROPE
  • ASIA-PACIFIC
    • JAPAN
    • CHINA
    • INDIA
    • SOUTH KOREA
    • AUSTRALIA
    • SINGAPORE
    • MALAYSIA
    • THAILAND
    • INDONESIA
    • PHILIPPINES
    • REST OF ASIA PACIFIC
  • SOUTH AMERICA
    • BRAZIL
    • ARGENTINA
    • COLOMBIA
    • REST OF SOUTH AMERICA
  • MIDDLE EAST AND AFRICA
    • SAUDI ARABIA
    • UAE
    • EGYPT
    • NIGERIA
    • SOUTH AFRICA
    • REST OF  MIDDLE EAST AND AFRICA

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.